Zhonghua zhong liu za zhi [Chinese journal of oncology]
-
Zhonghua Zhong Liu Za Zhi · Jan 2000
Case Reports[The use of interposed colon for endothoracic anastomosis in esophageal surgery].
To study the use of interposed colon for endothoracic anastomosis in esophageal surgery. ⋯ The interposed colon for endothoracic anastomosis is a comparatively ideal method for the reconstruction of esophagus following resection of cancer of mid and lower thind of the esophagus.
-
Zhonghua Zhong Liu Za Zhi · Mar 1999
[Surgical treatment of ovarian malignant tumors metastasized to the gastro-intestinal tract: a report of 131 cases].
To investigate the value and feasibility of surgical excision of gastro-intestinal metastatic tumors in patients with ovarian malignancy. ⋯ Surgical excision of gastro-intestinal tumors metastasized from primary ovarion malignancies is feasible to achieve cytoreduction. Prognosis can be improved when combined with chemotherapy.
-
Zhonghua Zhong Liu Za Zhi · Mar 1998
[Application of pectoralis major myocutaneous flap in the reconstruction of tongue: an analysis of 86 cases].
To analyze the results of the use of pectoralis major myocutaneous (PMM) flap in the reconstruction of tongue. ⋯ The PMM flap with its abundant tissue and excellent blood supply and anatomic proximity provides a reliable method of primary reconstruction of the substance of the tongue. The surgical procedure is simple, easy to perform. Reconstruction of the tongue with PMM flap meets the clinical requirements in the shape, communication and swallowing rehabilitations. The PMM flap is a reliable material for the reconstruction of tongue with major defect following subtotal glossectomy.
-
Zhonghua Zhong Liu Za Zhi · Nov 1997
Multicenter Study Clinical Trial[Phase III clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by non-cisplatin chemotherapy].
This study was undertaken to further determine the clinical value of ondansetron (OND, supplied by Qilu Pharmaceutical Company) in the prophylaxis of nausea and vomiting induced by non-cisplatin chemotherapy. ⋯ This modified regimen of treatment with OND is effective in the control of vomiting induced by non-DDP chemotherapy.
-
Zhonghua Zhong Liu Za Zhi · Sep 1997
Multicenter Study Clinical Trial[Phase III clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by cisplatin].
To further evaluate the clinical usefulness of ondensetron(OND, supplied by Qilu Pharmaceutical Company) with modified regime in the prevention of cisplatin (DDP)-induced nausea and vomiting. ⋯ OND with modified regimen is effective in the control of DDP-induced vomiting. It is more effective when OND and DXM are given than OND given alone.